On Thursday, the Union Government said that the Union Health Ministry has begun the clinical trials of traditional medicines like Ashwagandha, Guduchi Pippali, Yashtimadhu amidst the lack of medicines and vaccines to cure the coronavirus.
Union Health Minister, Harsh Vardhan spoke to the media agency ANI where he confirmed that the clinical trials have begun. He said,
“The clinical trials of traditional medicines like Ashwagandha, Yashtimadhu, Guduchi Pippali, Ayush-64 on health workers, and those working in high-risk areas have begun from today.”
The minister further said that the clinical trials will be in collaboration with the Union Health Ministry and will be carried out along with the standard protocol care to the COVID-19 patients. Harsh Vardhan added,
“The clinical trial would be done as a joint initiative of Ministry of AYUSH, Ministry of Health and Family Welfare and the Ministry of Science and Technology through Council of Scientific and Industrial Research (CSIR) with technical support from the Indian Council of Medical Research.”
The Minister further said that the Ministry of AYUSH will also be studying the impact of Ayush-based prophylactic interventions in people who work in high-risk areas and amidst high-risk populations.
Curve refuses to flatten in the country
Meanwhile, India’s COVID-19 situation refuses to slow down. India’s coronavirus figures have crossed the 50,000 mark as it has reported 53,057 cases as of now. 15,332 people have recovered and 1,787 have died due to the virus. Currently, there are 35,934 cases that are active. Maharashtra, Gujarat, Delhi and Tamil Nadu have been the worst-hit states with maximum cases come out of these states.
Maharashtra has recorded 16,758 positive cases out of which 13,013 are active. Maharashtra has so far conducted 1,81,746 tests in the state. As per the statistics, 137 people in a million population in Maharashtra are said to be infected by the novel coronavirus. The mortality rate of the state is 3.88 which is close to the national average. The recovery rate, however, is below the national average at 18.46 percent. Out of every 1 million people, Maharashtra has conducted 1411 tests. Over 10,000 of those cases are from the capital city of Mumbai followed by Pune with 2087 cases.
Source: Livemint
